Skip to content
OpenFederal grantOpen to for-profit businessesRFA-NS-28-012

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

National Institutes of HealthCloses Oct 10, 2028(692 days left)Up to $2,500,000

Does this fit your business?

This is an NIH translational research grant for genome editing and biologic therapies targeting Alzheimer's Disease-Related Dementias, covering lead optimization through IND-enabling studies and manufacturing development. It is for research organizations and biotech businesses doing that specific work. If you are not developing therapies for ADRD, do not apply.

Best for
Biotech and life-science small businesses developing ADRD therapies, Universities and research institutions, Nonprofits doing translational dementia research, Genome editing and drug development teams
Not for
Retail, food, transportation, or software companies with no biologic therapy work, Businesses seeking general operating or commercialization funding, Organizations outside the ADRD therapeutic space
Estimated fit by industry, best first
IndustryEstimated fit
Healthcare & BiotechMatches your industry (clinical)
74
Good Match
Arts & CultureLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Education & TrainingMatches your industry (stem)
54
Possible Match
Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech
54
Possible Match
Environment & ConservationLimit: Nothing in this notice points to environment & conservation
54
Possible Match
Housing & Real EstateLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Show all 15 industries
Estimated fit by industry, best first
IndustryEstimated fit
ManufacturingMatches your industry (manufacturing)
54
Possible Match
Social Services & NonprofitLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Technology & SoftwareLimit: Nothing in this notice points to technology & software
54
Possible Match
Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming
52
Possible Match
Finance & BankingLimit: Nothing in this notice points to finance & banking
50
Possible Match
Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure
49
Possible Match
Food & BeverageLimit: Nothing in this notice points to food & beverage
49
Possible Match
Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce
49
Possible Match
Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics
49
Possible Match

These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.

What this funds

Money can be used for
Research, R&D
Who can apply
Small businesses, For-profit companies, Nonprofits, State and local governments, Tribal governments and organizations, Colleges and universities, Other applicants (see eligibility)
Award range
Up to $2,500,000

Questions about this grant

When is the application deadline?
The application deadline is October 10, 2028. The notice was posted on November 3, 2026.
How much funding can an applicant receive?
The largest single award is $2,500,000, with total program funding of $6,000,000 and about 3 awards expected. No cost sharing is required.
Who can apply for this grant?
Eligible applicants include small businesses, for-profit organizations, nonprofits with and without 501(c)(3) status, state and local governments, tribal governments and organizations, public housing authorities, independent school districts, and institutions of higher education. The eligibility text also lists federal agencies, U.S. territories, faith-based and community-based organizations, regional organizations, and foreign institutions.
Can a sole proprietor or single-member LLC apply?
The facts confirm that small businesses may apply, but they do not specifically address sole proprietors or single-member LLCs. Check the full eligibility text on Grants.gov before assuming you qualify.
Can a nonprofit apply?
Yes. Both nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status (other than institutions of higher education) are listed as eligible applicants.

Summary

NIH-funded translational research grants for genome editing and biologic therapies targeting Alzheimer's Disease-Related Dementias, covering lead optimization, IND-enabling studies, safety/toxicology, and manufacturing development. Eligible applicants include small businesses, for-profits, universities, nonprofits, governments, and tribal entities.

About this grant

This Notice of Funding Opportunity (NOFO) supports the translation of genome editing and other biologic therapies for Alzheimer's Disease-Related Dementias (ADRD). The program spans the full translational pipeline, from therapeutic lead optimization and drug product development through IND-enabling studies and early clinical evaluation. Supported activities may include optimization of editing constructs and delivery systems; assessment of bioactivity, target engagement, durability, pharmacokinetics, and bioavailability; demonstration of in vivo efficacy; execution of safety pharmacology and toxicology studies; and development of scalable manufacturing processes, formulation strategies, and quality attributes aligned with regulatory expectations. ADRD include Frontotemporal Dementia (FTD); Lewy Body Dementias (LBD), including Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD); Vascular Contributions to Cognitive Impairment and Dementia (VCID); and Multiple Etiology Dementias (MED).

Who can apply

Other Eligible ApplicantsEligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Topics and uses of funds

Topics

  • Health
  • Science

Program contact

National Institutes of Healthnindsdonadrd@mail.nih.gov301-402-2541

Open opportunities funding similar work, from the same funder or in the same place.